Pacific Biosciences of California, Inc. Overview
Pro stress-test →Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. The company focuses on high-quality, highly accurate sequencing technologies, including HiFi long-read sequencing, to help scientists and clinical researchers resolve genetically complex problems across a broad set of research applications.
Strategic Profile
Pro stress-test →Pacific BioSciences of California was founded in 2004. The company operates in genomics sequencing instrumentation with products used in research and emerging clinical applications. However, the company faces significant financial challenges including substantial operational losses and declining revenue growth.
Competitive Landscape
Pro stress-test →One of Pacific BioSciences of California's 20 competitors is Cytek Biosciences, a Formerly VC-backed company based in Fremont, CA. The sequencing market is highly competitive with larger players like Illumina dominating market share. PacBio's long-read sequencing technology differentiates it but faces pressure from cost and adoption challenges.
Industry Context
Pacific Biosciences of California, Inc. operates in Biotechnology / Life Sciences Instrumentation.
Key facts
Founded: 2004 · Headquarters: Menlo Park, US · Revenue: $160M · Market cap: $477M